---
schema_version: "secwatch.filing_event.v1"
accession: "0000776901-26-000061"
form_type: "8-K"
ticker: "INDB"
cik: "0000776901"
company_name: "INDEPENDENT BANK CORP"
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:55:04.271838+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# INDB CEO Jeff Tengel diagnosed with lymphoma, expects full recovery, will continue working

## Summary
- CEO Jeffrey Tengel disclosed a Lymphoma diagnosis; has begun chemotherapy.
- Tengel expects full recovery, plans to continue working with schedule adjustments.
- Board and Executive Leadership Team are fully supportive; strategy remains unchanged.
- Tengel may reduce attendance at large gatherings during treatment for health precautions.

## SEC filing metadata
- accession: 0000776901-26-000061
- form_type: 8-K
- ticker: INDB
- cik: 0000776901
- company_name: INDEPENDENT BANK CORP
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/776901/000077690126000061/0000776901-26-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/776901/000077690126000061/indb-20260304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000776901-26-000061
- JSON: https://secwatch.observer/filing/0000776901-26-000061.json
- Plain text: https://secwatch.observer/filing/0000776901-26-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.